Publications

Hu, Zhibin, Minhua Shao, Jing Yuan, Liang Xu, Feng Wang, Yi Wang, Wentao Yuan, et al. “Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study..” Carcinogenesis 27, no. 7 (July 2006): 1475–80. https://doi.org/10.1093/carcin/bgi350.

PMID
16522664
Full Text

Zebrack, B. J., K. C. Oeffinger, P. Hou, and S. Kaplan. “Advocacy skills training for young adult cancer survivors: the Young Adult Survivors Conference at Camp Māk-a-Dream..” Support Care Cancer 14, no. 7 (July 2006): 779–82. https://doi.org/10.1007/s00520-005-0906-4.

PMID
16482447
Full Text

Zhu, J., A. Rashid, K. Cleary, J. L. Abbruzzese, H. Friess, S. Takahashi, T. Shirai, and D. Li. “Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)-DNA adducts in human pancreatic tissues..” Biomarkers 11, no. 4 (July 2006): 319–28. https://doi.org/10.1080/13547500600667911.

PMID
16908439
Full Text

Hauck, Marlene L., Susan M. LaRue, William P. Petros, Jean M. Poulson, Daohai Yu, Ivan Spasojevic, Amy F. Pruitt, et al. “Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors..” Clin Cancer Res 12, no. 13 (July 1, 2006): 4004–10. https://doi.org/10.1158/1078-0432.CCR-06-0226.

PMID
16818699
Full Text

Smith, Thomas J., James Khatcheressian, Gary H. Lyman, Howard Ozer, James O. Armitage, Lodovico Balducci, Charles L. Bennett, et al. “2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline..” J Clin Oncol 24, no. 19 (July 1, 2006): 3187–3205. https://doi.org/10.1200/JCO.2006.06.4451.

PMID
16682719
Full Text

Lyman, Gary H. “Benefits of early intervention with erythropoiesis- stimulating proteins in chemotherapy-induced anemia..” Oncology (Williston Park) 20, no. 8 Suppl 6 (July 2006): 16–20.

PMID
16925106
Scholars@Duke

Hu, Zhibin, Liang Xu, Minhua Shao, Jing Yuan, Yi Wang, Feng Wang, Wentao Yuan, et al. “Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population..” Cancer Epidemiol Biomarkers Prev 15, no. 7 (July 2006): 1336–40. https://doi.org/10.1158/1055-9965.EPI-06-0194.

PMID
16835333
Full Text

Abdelrahim, Maen, Cheryl H. Baker, James L. Abbruzzese, and Stephen Safe. “Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation..” J Natl Cancer Inst 98, no. 12 (June 21, 2006): 855–68. https://doi.org/10.1093/jnci/djj232.

PMID
16788159
Full Text

Heery, C. R., A. Desjardins, J. A. Quinn, J. N. Rich, S. Gururangan, J. J. Vredenburgh, A. H. Friedman, D. A. Reardon, and H. S. Friedman. “Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation therapy for primary high-grade glioma..” J Clin Oncol 24, no. 18_suppl (June 20, 2006).

PMID
27954360
Scholars@Duke

Reardon, D., J. A. Quinn, J. N. Rich, J. J. Vredenburgh, A. Desjardins, S. Sathornsumetee, S. Gururangan, M. J. Egorin, A. Salvado, and H. S. Friedman. “A phase I trial of imatinib, hydroxyurea and RAD001 for patients with recurrent malignant glioma..” In Journal of Clinical Oncology, 24:77S-77S. AMER SOC CLINICAL ONCOLOGY, 2006.

Scholars@Duke

Pages